- Activity pressure is positive on the latest completed week.
M7T
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Mach7 Technologies Limited · Healthcare · Health Information Services
Latest close
0.28 AUD
-3.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -11.7% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned -3.4%, after a -8.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
23
out of 100
Latest Close
0.28 AUD
7 Aug 2026
1W Return
-3.4%
latest completed week
4W Return
-8.1%
short-term follow-through
12W Return
-1.7%
quarterly tape
Trend Breadth
17.3%
9 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 39.99% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.4%
Latest completed week; four-week move -8.1%.
Indicator stack
10/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.99%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -11.7% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned -3.4%, after a -8.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals3Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.1% over four weeks, -1.7% over 12 weeks, and -25.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.13Latest activity-pressure read.
Pressure change-4.6%Four-week change in activity pressure.
Leadership-23.21Latest relative-leadership reading.
RS change-65.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2024
Field coverage 70%
Model confidence 21%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.
Quality13/100Profitability and accounting quality. Underlying universe rank 88; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 3.9x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 7.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 91.6% Gross profit retained from each unit of revenue.
- Operating margin
- -129.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 17.7% Free cash flow generated from revenue.
- Return on invested capital
- -53.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -14.9% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 0/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.3% Net share repurchases relative to market value.
- Shareholder yield
- -0.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-58.4%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2616 weeks finished lower.
Best week+21.2%Week of 3 Apr.
Worst week-8.6%Week of 20 Mar.
Latest week-3.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains2
Flat weeks3
Modest losses8
Sharp losses8
Recent vol5.1%13-week weekly-return volatility.
Base vol8.9%52-week weekly-return volatility.
Up/down split16/28Count of positive and negative weeks in the 52-week window.
Average skew10.0% / -6.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank69 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Health Information Services
4-week rank12 / 25
Group average-5.6%
Trend breadth28.0%
Trend28.0%active weekly trend signals
MD52.0%positive activity pressure
RS28.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.24; No reversal markers Next-Week ExpectancyNegative 39.99%Next-week expectancy is negative with a 39.99% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors38/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 68; Small Cap Core rank 82 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Mach7 Technologies Limited (ASX:M7T) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.28 AUD | -3.4% | 0.32 AUD | 0.48 AUD | 0.13 | -23.21 | 529.9K | Off |
| 31 Jul 2026 | 0.29 AUD | 0.0% | 0.33 AUD | 0.49 AUD | 0.16 | -18.46 | 438.7K | Off |
| 24 Jul 2026 | 0.29 AUD | -3.3% | 0.35 AUD | 0.49 AUD | 0.13 | -16.95 | 378.1K | Off |
| 17 Jul 2026 | 0.30 AUD | -1.6% | 0.35 AUD | 0.49 AUD | 0.13 | -14.99 | 481.1K | Off |
| 10 Jul 2026 | 0.31 AUD | 5.1% | 0.36 AUD | 0.50 AUD | 0.14 | -14.02 | 359.8K | Off |
| 3 Jul 2026 | 0.29 AUD | 0.0% | 0.37 AUD | 0.50 AUD | 0.10 | -18.77 | 66.5K | Off |
| 26 Jun 2026 | 0.29 AUD | -6.3% | 0.38 AUD | 0.51 AUD | 0.18 | -18.22 | 191.9K | Off |
| 19 Jun 2026 | 0.32 AUD | 5.0% | 0.38 AUD | 0.51 AUD | 0.19 | -13.59 | 296.1K | Off |
| 12 Jun 2026 | 0.30 AUD | -6.3% | 0.39 AUD | 0.51 AUD | 0.21 | -17.66 | 153.1K | Off |
| 5 Jun 2026 | 0.32 AUD | -3.0% | 0.39 AUD | 0.51 AUD | 0.23 | -10.56 | 1.1M | Off |
| 29 May 2026 | 0.33 AUD | 1.5% | 0.39 AUD | 0.51 AUD | 0.05 | -9.06 | 512.3K | Off |
| 22 May 2026 | 0.33 AUD | 12.1% | 0.39 AUD | 0.51 AUD | -0.23 | -9.92 | 1.3M | Off |
| 15 May 2026 | 0.29 AUD | 5.5% | 0.38 AUD | 0.52 AUD | -0.55 | -19.67 | 2.1M | Off |
| 8 May 2026 | 0.28 AUD | 3.8% | 0.38 AUD | 0.52 AUD | -0.84 | -25.22 | 2.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.